Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Cetrelimab
Janssen Cilag International NV
Carcinoma, Non-Small-Cell Lung
1 trial -
Erdafitinib Intravesical Delivery System
Janssen Cilag International NV
Non-Muscle Invasive Bladder Neoplasms
1 trial -
Guselkumab
Janssen Cilag International NV
Colitis, Ulcerative
1 trial -
JNJ-40411813
Janssen Cilag International NV
Focal Onset Seizures
1 trial -
JNJ-64281802
Janssen Cilag International NV
Dengue
2 trials -
JNJ-73763989
Janssen Cilag International NV
Hepatitis B, Chronic
1 trial -
JNJ-77242113
Janssen Cilag International NV
Colitis, Ulcerative
1 trial -
Lumicitabine
Janssen Cilag International NV
Respiratory Syncytial Viruses
1 trial -
Lumicitabine
Janssen Cilag International NV
Respiratory Syncytial Virus Infections
1 trial -
Placebo
Janssen Cilag International NV
Depressive Disorder, Major
1 trial -
Rilematovir
Janssen Cilag International NV
Respiratory Syncytial Virus
1 trial -
Rilpivirine
Janssen Cilag International NV
HIV-1
1 trial -
Siltuximab
Janssen Cilag International NV
Multicentric Castleman's Disease
1 trial -
TMC207
Janssen Cilag International NV
Tuberculosis
1 trial -
Acetaminophen
Janssen Cilag International NV
Healthy
1 trial -
Ad26.COV2.S
Janssen Cilag International NV
Healthy
1 trial -
Hydromorphone 16 mg
Janssen Cilag International NV
Healthy Volunteers
1 trial -
JNJ-53718678
Janssen Cilag International NV
Respiratory Syncytial Virus Infections
1 trial -
JNJ-56021927
Janssen Cilag International NV
Prostatic Neoplasms, Castration-Resistant
1 trial -
Guselkumab
Janssen Cilag International NV
Arthritis, Psoriatic
3 trials -
OROS hydromorphone
Janssen Cilag International NV
Cancer Pain
1 trial -
Topiramate
Janssen Cilag International NV
Epilepsy
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources